May 25, 2022 — MedStar Heart & Vascular Institute announced that Thomas E. MacGillivray, MD, has been named physician ...
May 24, 2022 — Amarin Corporation plc announced that research on the potential population health impact and cost ...
May 24, 2022 — Attune Medical, a pioneering medical device company with a technology platform based on temperature ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
May 24, 2022 — The U.S. Food and Drug Administration (FDA) has issued a statement that Teva Pharmaceuticals USA has ...
May 24, 2022 — Anumana, Inc., an AI-driven health technology company from nference, Inc., today announced that the U.S ...
May 23, 2022 — A specific protein in blood vessel cells plays a major role in the development of vascular and ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 23, 2022 — New data from a study of more than 100 million hospitalizations using machine learning augmentation was ...
May 23, 2022 — New findings from the Ascension Health System’s internal National Cardiovascular Data Registry (NCDR) ...
May 23, 2022 — Insights from a National Inpatient Sample Database examining race and the rates of cardiac ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 20, 2022 — Results from a retrospective analysis reveal significantly higher mortality rates for low-income ...
May 20, 2022 — Results from a real-world study investigating safety and effectiveness of clopidogrel versus aspirin ...
May 20, 2022 — Results from early clinical evaluation of the Alleviant System to treat heart failure patients with ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
May 20, 2022 — A new analysis of PROGRESS-CTO (PROspective Global REgiStry for the Study of Chronic Total Occlusion ...
May 20, 2022 — New long-term data from the Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel ...
May 20, 2022 — Abbott announced two late-breaking data presentations highlighting both TriClip, a first-of-its kind ...